Used in pharmaceutical research as a structural analog for dopamine receptor ligands, particularly in the development of compounds targeting central nervous system disorders. Shows potential in studies related to neurodegenerative diseases and psychiatric conditions due to its interaction with monoaminergic systems. Also investigated for its psychoactive properties and possible use in cognitive enhancement or treatment of mood disorders. Not approved for clinical use; primarily employed in preclinical research and forensic analysis.